1.Langley, JM, LeBlanc, JC, Hanakowski, M, Goloubeva, O. The role of Clostridium difficile and viruses as causes of nosocomial diarrhea in children. Infect Control Hosp Epidemiol 2002;23:660–664.10.1086/501990
2.Magill, SS, Edwards, JR, Bamberg, W, et al. Multistate point-prevalence survey of health care–associated infections. N Engl J Med 2014;370:1198–1208.10.1056/NEJMoa1306801
3.Nylund, CM, Goudie, A, Garza, JM, Fairbrother, G, Cohen, MB. Clostridium difficile infection in hospitalized children in the United States. Arch Pediatr Adolesc Med 2011;165:451–457.10.1001/archpediatrics.2010.282
4.Khanna, S, Baddour, LM, Huskins, WC, et al. The epidemiology of Clostridium difficile infection in children: a population-based study. Clin Infect Dis 2013;56:1401–1406.10.1093/cid/cit075
5.Sammons, JS, Localio, R, Xiao, R, Coffin, SE, Zaoutis, T. Clostridium difficile infection is associated with increased risk of death and prolonged hospitalization in children. Clin Infect Dis 2013;57:1–8.10.1093/cid/cit155
6.Zilberberg, MD, Tillotson, GS, McDonald, LC. Clostridium difficile infections among hospitalized children, United States, 1997–2006. Emerg Infect Dis 2010;16:604–609.10.3201/eid1604.090680
7.Toltzis, P, Kim, J, Dul, M, Zoltanski, J, Smathers, S, Zaoutis, T. Presence of the epidemic North American pulsed-field type 1 Clostridium difficile strain in hospitalized children. J Pediatr 2009;154:607–608.10.1016/j.jpeds.2008.10.016
8.Gupta, A, Pardi, DS, Baddour, LM, Khanna, S. Outcomes in children with Clostridium difficile infection: results from a nationwide survey. Gastroenterol Rep 2016;4:293–298.
9.McDonald, LC, Gerding, DN, Johnson, S, et al. Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 2018;66(7):e1–e48.10.1093/cid/cix1085
10.Sandora, TJ, Fung, M, Flaherty, K, et al. Epidemiology and risk factors for Clostridium difficile infection in children. Pediatr Infect Dis J 2011;30:580–584.10.1097/INF.0b013e31820bfb29
11.Dulęba, K, Pawłowska, M, Wietlicka-Piszcz, M. Clostridium difficile infection in children hospitalized due to diarrhea. Eur J Clin Microbiol Infect Dis 2014;33:201–209.10.1007/s10096-013-1946-1
12.Turco, R, Martinelli, M, Miele, E, et al. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Aliment Pharmacol Ther 2010;31:754–759.10.1111/j.1365-2036.2009.04229.x
13.McFarland, LV, Brandmarker, SA, Guandalini, S. Pediatric Clostridium difficile: a phantom menace or clinical reality? J Pediatr Gastroenterol Nutr 2000;31:220–231.10.1097/00005176-200009000-00004
14.Moher, D, Liberati, A, Tetzlaff, J, Altman, DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–269.10.7326/0003-4819-151-4-200908180-00135
16.DerSimonian, R, Laird, N. Meta-analysis in clinical trials. Control Clin Trial 1986;7:177–188.10.1016/0197-2456(86)90046-2
17.Deeks, JJ, Higgins, JP, Altman, DG. Analysing data and undertaking meta-analyses. In: Higgins, JPT and Green, S (editors). Cochrane Handbook for Systematic Reviews of Interventions. New York: John Wiley & Sons; 2008. Pp. 243–296.10.1002/9780470712184.ch9
18.Duval, S, Tweedie, R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000;56:455–463.10.1111/j.0006-341X.2000.00455.x
19.Kim, J, Smathers, SA, Prasad, P, Leckerman, KH, Coffin, S, Zaoutis, T. Epidemiological features of Clostridium difficile-associated disease among inpatients at children’s hospitals in the United States, 2001–2006. Pediatrics 2008;122:1266–1270.10.1542/peds.2008-0469
20.Pant, C, Anderson, MP, Deshpande, A, et al. Health care burden of Clostridium difficile infection in hospitalized children with inflammatory bowel disease. Inflamm Bowel Dis 2013;19:1080–1085.10.1097/MIB.0b013e3182807563
21.Dethlefsen, L, Huse, S, Sogin, ML, Relman, DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLOS Biol 2008;6(11):e280.10.1371/journal.pbio.0060280
22.Slimings, C, Riley, TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. J Antimicrob Chemother 2014;69:881–891.10.1093/jac/dkt477
23.Adams, DJ, Eberly, MD, Rajnik, M, Nylund, CM. Risk factors for community-associated Clostridium difficile infection in children. J Pediatr 2017;186:105–109.10.1016/j.jpeds.2017.03.032
24.Hojsak, I, Ferenc, T, Bojanić, K, et al. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients. Digestion 2012;86:6–11.10.1159/000337357
25.Seto, CT, Jeraldo, P, Orenstein, R, Chia, N, DiBaise, JK. Prolonged use of a proton pump inhibitor reduces microbial diversity: implications for Clostridium difficile susceptibility. Microbiome 2014;2:42.10.1186/2049-2618-2-42
26.Jump, RLP, Pultz, MJ, Donskey, CJ. Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea? Antimicrob Agents Chemother 2007;51:2883–2887.10.1128/AAC.01443-06
27.Oshima, T, Wu, L, Li, M, Fukui, H, Watari, J, Miwa, H. Magnitude and direction of the association between Clostridium difficile infection and proton pump inhibitors in adults and pediatric patients: a systematic review and meta-analysis. J Gastroenterol 2018;53:84–94.10.1007/s00535-017-1369-3
28.Brown, KE, Knoderer, CA, Nichols, KR, Crumby, AS. Acid-suppressing agents and risk for Clostridium difficile infection in pediatric patients. Clin Pediatr (Phila) 2015;54:1102–1106.10.1177/0009922815569201
29.Pascarella, F, Martinelli, M, Miele, E, Del Pezzo, M, Roscetto, E, Staiano, A. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. J Pediatr 2009;154:854–858.10.1016/j.jpeds.2008.12.039
30.Sinh, P, Barrett, TA, Yun, L. Clostridium difficile infection and inflammatory bowel disease: a review. Gastroenterol Res Pract 2011;2011:136064.
31.Pant, C, Deshpande, A, Desai, M, et al. Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients. Transpl Infect Dis 2016;18:31–36.10.1111/tid.12477
32.de Blank, P, Zaoutis, T, Fisher, B, Troxel, A, Kim, J, Aplenc, R. Trends in Clostridium difficile infection and risk factors for hospital acquisition of Clostridium difficile among children with cancer. J Pediatr 2013;163:699–705.e1.
33.Guo, S, Xu, X, Dong, F. Risk factors of Clostridium difficile-associated diarrhea in children. Zhonghua Yi Xue Za Zhi 2012;92:1836–1840.
34.Price, V, Portwine, C, Zelcer, S, et al. Clostridium difficile infection in pediatric acute myeloid leukemia: from the Canadian Infections in Acute Myeloid Leukemia Research Group. Pediatr Infect Dis J 2013;32:610–613.
35.Santiago, B, Guerra, L, García-Morín, M, et al. Clostridium difficile isolation in children hospitalized with diarrhea. An Pediatr 2015;82:417–425.
36.Ciricillo, J, Haslam, D, Blum, S, et al. Frequency and risks associated with Clostridium difficile-associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Transpl Infect Dis 2016;18:706–713.
37.Finnerty, CC, Herndon, DN, Lee, JO, et al. Morbidity and mortality in severely burned children with Clostridium difficile-associated diarrhea. Surgery 2016;159:1631–1637.
38.Karaaslan, A, Soysal, A, Yakut, N, et al. Hospital-acquired Clostridium difficile infection in pediatric wards: a retrospective case-control study. SpringerPlus 2016;5:1329.
39.Daida, A, Yoshihara, H, Inai, I, et al. Risk factors for hospital-acquired Clostridium difficile infection among pediatric patients with cancer. J Pediatr Hematol Oncol 2017;39:e167–e172.